Related Experiment Video
Updated: Aug 4, 2025

06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.3K
Menopause hormone treatment after cancer
1Université Paris Cité, Paris, France.
Summary
Menopause hormone therapy (MHT) can alleviate cancer treatment symptoms but has contraindications. MHT may be suitable for ovarian and cervical cancers, but requires caution in breast and endometrial cancer survivors.
Area of Science:
- Oncology
- Gynecology
- Endocrinology
Background:
- Cancer survivors often experience severe menopausal symptoms impacting quality of life.
- Menopause hormone therapy (MHT) is effective for symptom relief but its use in cancer patients is complex.
- Estrogen deficiency long-term effects can be mitigated by MHT, but oncologic contraindications exist.
Purpose of the Study:
- To review the safety and efficacy of MHT in cancer survivors.
- To analyze MHT use in patients with breast, ovarian, endometrial, and cervical cancers.
- To provide guidance on MHT application in various gynecologic cancer contexts.
Main Methods:
- Review of randomized trials and clinical guidelines.
- Analysis of MHT effects based on cancer type and hormone-dependency.
- Evaluation of survival data and symptom management outcomes.
Main Results:
- MHT is generally not recommended for breast cancer survivors.
- Evidence suggests MHT may improve survival in serous high-grade ovarian carcinoma.
- MHT use in endometrial cancer requires further data; progestogen is a safer alternative.
- MHT is permissible for squamous cell cervical carcinoma but restricted for adenocarcinoma.
- Genomic profiling may personalize future MHT decisions.
Conclusions:
- MHT application in cancer survivors is cancer-type specific and requires careful consideration.
- Further research, particularly on molecular profiles, is needed to optimize MHT use.
- Progestogen therapy offers a viable option for symptom management when MHT is contraindicated.
Related Concept Videos
Menopause
217
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
217
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Disorders of the Female Reproductive System
427
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
427
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Cancer Survival Analysis
406
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
406

